These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 26540451)
1. Expectant management of veterans with early-stage prostate cancer. Filson CP; Shelton JB; Tan HJ; Kwan L; Skolarus TA; Saigal CS; Litwin MS Cancer; 2016 Feb; 122(4):626-33. PubMed ID: 26540451 [TBL] [Abstract][Full Text] [Related]
2. Variation in the use of active surveillance for low-risk prostate cancer. Löppenberg B; Friedlander DF; Krasnova A; Tam A; Leow JJ; Nguyen PL; Barry H; Lipsitz SR; Menon M; Abdollah F; Sammon JD; Sun M; Choueiri TK; Kibel AS; Trinh QD Cancer; 2018 Jan; 124(1):55-64. PubMed ID: 28902401 [TBL] [Abstract][Full Text] [Related]
3. Population-Based Assessment of Determining Treatments for Prostate Cancer. Chamie K; Williams SB; Hu JC JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305 [TBL] [Abstract][Full Text] [Related]
4. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer. Filson CP; Schroeck FR; Ye Z; Wei JT; Hollenbeck BK; Miller DC J Urol; 2014 Jul; 192(1):75-80. PubMed ID: 24518783 [TBL] [Abstract][Full Text] [Related]
5. Utilization of Active Surveillance and Watchful Waiting for localized prostate cancer in the daily practice. Herden J; Weissbach L World J Urol; 2018 Mar; 36(3):383-391. PubMed ID: 29330583 [TBL] [Abstract][Full Text] [Related]
6. Active Surveillance for Men with Intermediate Risk Prostate Cancer. Agrawal V; Ma X; Hu JC; Barbieri CE; Nagar H J Urol; 2021 Jan; 205(1):115-121. PubMed ID: 32658588 [TBL] [Abstract][Full Text] [Related]
7. Regional Variation in Active Surveillance for Low-Risk Prostate Cancer in the US. Washington SL; Jeong CW; Lonergan PE; Herlemann A; Gomez SL; Carroll PR; Cooperberg MR JAMA Netw Open; 2020 Dec; 3(12):e2031349. PubMed ID: 33369661 [TBL] [Abstract][Full Text] [Related]
8. Treatment patterns for older veterans with localized prostate cancer. Hoffman RM; Shi Y; Freedland SJ; Keating NL; Walter LC Cancer Epidemiol; 2015 Oct; 39(5):769-77. PubMed ID: 26228494 [TBL] [Abstract][Full Text] [Related]
9. Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer. Shavers VL; Brown M; Klabunde CN; Potosky AL; Davis W; Moul J; Fahey A Med Care; 2004 Mar; 42(3):239-50. PubMed ID: 15076823 [TBL] [Abstract][Full Text] [Related]
10. Physician variation in management of low-risk prostate cancer: a population-based cohort study. Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650 [TBL] [Abstract][Full Text] [Related]
11. Nationwide treatment patterns and survival of older patients with prostate cancer. Vernooij RWM; van Oort I; de Reijke TM; Aben KKH J Geriatr Oncol; 2019 Mar; 10(2):252-258. PubMed ID: 30853064 [TBL] [Abstract][Full Text] [Related]
12. The Long-Term Risks of Metastases in Men on Active Surveillance for Early Stage Prostate Cancer. Maggi M; Cowan JE; Fasulo V; Washington SL; Lonergan PE; Sciarra A; Nguyen HG; Carroll PR J Urol; 2020 Dec; 204(6):1222-1228. PubMed ID: 33157570 [TBL] [Abstract][Full Text] [Related]
13. Changing Trends in Surgical Management of Prostate Cancer: The End of Overtreatment? Huland H; Graefen M Eur Urol; 2015 Aug; 68(2):175-8. PubMed ID: 25736732 [TBL] [Abstract][Full Text] [Related]
14. The feasibility of expectant management with inner-city men with newly diagnosed localized prostate cancer. Anai S; Nakamura K; Chang MN; Pendleton J; Yacoub S; Rosser CJ J Health Care Poor Underserved; 2008 Feb; 19(1):164-70. PubMed ID: 18263992 [TBL] [Abstract][Full Text] [Related]
15. Pathologic Outcomes in Favorable-risk Prostate Cancer: Comparative Analysis of Men Electing Active Surveillance and Immediate Surgery. Tosoian JJ; Sundi D; Trock BJ; Landis P; Epstein JI; Schaeffer EM; Carter HB; Mamawala M Eur Urol; 2016 Apr; 69(4):576-581. PubMed ID: 26456680 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). Schymura MJ; Kahn AR; German RR; Hsieh MC; Cress RD; Finch JL; Fulton JP; Shen T; Stuckart E BMC Cancer; 2010 Apr; 10():152. PubMed ID: 20403178 [TBL] [Abstract][Full Text] [Related]
17. Long-term Impact of Adjuvant Versus Early Salvage Radiation Therapy in pT3N0 Prostate Cancer Patients Treated with Radical Prostatectomy: Results from a Multi-institutional Series. Fossati N; Karnes RJ; Boorjian SA; Moschini M; Morlacco A; Bossi A; Seisen T; Cozzarini C; Fiorino C; Noris Chiorda B; Gandaglia G; Dell'Oglio P; Joniau S; Tosco L; Shariat S; Goldner G; Hinkelbein W; Bartkowiak D; Haustermans K; Tombal B; Montorsi F; Van Poppel H; Wiegel T; Briganti A Eur Urol; 2017 Jun; 71(6):886-893. PubMed ID: 27484843 [TBL] [Abstract][Full Text] [Related]
18. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer. Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425 [TBL] [Abstract][Full Text] [Related]
19. More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades. Eifler JB; Alvarez J; Koyama T; Conwill RM; Ritch CR; Hoffman KE; Resnick MJ; Penson DF; Barocas DA; J Urol; 2017 Mar; 197(3 Pt 1):614-620. PubMed ID: 27984110 [TBL] [Abstract][Full Text] [Related]
20. Factors Associated with Discontinuation of Active Surveillance among Men with Low-Risk Prostate Cancer: A Population-Based Study. Timilshina N; Komisarenko M; Martin LJ; Cheung DC; Alibhai S; Richard PO; Finelli A J Urol; 2021 Oct; 206(4):903-913. PubMed ID: 34412510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]